The JAK2-V617F mutation and essential thrombocythemia features in a subset of patients with refractory anemia with ring sideroblasts (RARS)

Blood. 2006 Sep 1;108(5):1781-2. doi: 10.1182/blood-2006-03-008227.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Aged, 80 and over
  • Amino Acid Substitution*
  • Anemia, Refractory / classification
  • Anemia, Refractory / enzymology
  • Anemia, Refractory / genetics*
  • Anemia, Sideroblastic / classification
  • Anemia, Sideroblastic / enzymology
  • Anemia, Sideroblastic / genetics*
  • DNA Primers
  • Female
  • Humans
  • Janus Kinase 2
  • Male
  • Mutation
  • Polymerase Chain Reaction
  • Protein-Tyrosine Kinases / genetics*
  • Proto-Oncogene Proteins / genetics*
  • Thrombocythemia, Essential / classification
  • Thrombocythemia, Essential / enzymology
  • Thrombocythemia, Essential / genetics*

Substances

  • DNA Primers
  • Proto-Oncogene Proteins
  • Protein-Tyrosine Kinases
  • JAK2 protein, human
  • Janus Kinase 2